Astrana Health (US.ASTH)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.ASTH · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 94.1% | ↑ |
| ROE | 1.8% | ↑ |
| Cash Conversion | 471.4% | ↑ |
| D/E Ratio | 1.33 | ↓ |
| Gross Margin | 11.0% | → |
US.ASTH (Astrana Health) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 94.1% ↑ ROE 1.8% ↑ Cash Conversion 471.4% ↑ D/E Ratio 1.33 ↓ Gross Margin 11.0% →
Key Metrics
US.ASTH (Astrana Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 94.1% ↑ROE 1.8% ↑Cash Conversion 471.4% ↑D/E Ratio 1.33 ↓Gross Margin 11.0% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies